Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML‐RARA, CBFB‐MYH11, and RUNX1‐RUNX1T1
Authors: Julius Lukes, Lucie Winkowska, Martina Zwyrtkova, Julia Starkova, Lucie Sramkova, Jan Stary, Jan Trka, Jan Zuna, Marketa Zaliova